共 8 条
[1]
Application of Rho-associated protein kinase (ROCK) inhibitor to human pluripotent stem cells[J] Hiroshi Kurosawa Journal of Bioscience and Bioengineering 2012,
[2]
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects[J] Sabine Klein;Marike Marjolijn Van Beuge;Michaela Granzow;Leonie Beljaars;Robert Schierwagen;Sibel Kilic;Iren Heidari;Sebastian Huss;Tilman Sauerbruch;Klaas Poelstra;Jonel Trebicka Journal of Hepatology 2012,
[3]
Targeting RhoA/ROCK pathway in pulmonary arterial hypertension[J] Sabina Antonela Antoniu Expert Opinion on Therapeutic Targets 2012,
[4]
Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats[J] Jonel Trebicka;Ludger Leifeld;Martin Hennenberg;Erwin Biecker;Andreas Eckhardt;Nicolas Fischer;Andrea Schulze Pr?bsting;Christoph Clemens;Frank Lammert;Tilman Sauerbruch;J?rg Heller Hepatology 2008,
[5]
Defective RhoA/Rho-Kinase Signaling Contributes to Vascular Hypocontractility and Vasodilation in Cirrhotic Rats[J] Gastroenterology 2006,
[6]
Signal transduction by G‐proteins; Rho‐kinase and protein phosphatase to smooth muscle and non‐muscle myosin II[J] Andrew P.Somlyo;Avril V.Somlyo The Journal of Physiology 2004,
[7]
ROCK Inhibitor Y-27632 Attenuates Stellate Cell Contraction and Portal Pressure Increase Induced by Endothelin-1[J] Norifumi Kawada;Shuichi Seki;Tetsuo Kuroki;Kenji Kaneda Biochemical and Biophysical Research Communications 1999,
[8]
Regulation of airway smooth muscle cell contractility by Ca2 signaling and sensitivity MJ Sanderson;P Delmotte;Y Bai;JF Perez-Zogbhi; Proceedings of the American Thoracic Society 2008,